Hippocampal-Sparing Radiation May Be Feasible in Pediatric Medulloblastoma
Research suggests hippocampal-sparing radiation may be feasible for pediatric patients with medulloblastoma because the risk of peri‐hippocampal recurrence is low.
Diagnosis & Disease Information
Intervention Improves Adherence to Antiepileptic Drug Guidelines for Brain Tumor
Results of a 16-week project to improve adherence to guidelines for prophylactic AED use in seizure-naive patients with newly diagnosed brain tumor.
Convection-Enhanced Delivery of Topotecan Active in Glioblastoma
Catheter pump system capable of CED of topotecan well tolerated and active in recurrent glioblastoma.
Women With Glioblastoma May Be More Likely to Benefit From Immunotherapy
Among glioblastoma patients, women may derive more benefit from immunotherapy than men, research suggests.
Predicting Outcomes of Regorafenib in Patients With Recurrent Glioblastoma
Researchers say they have identified a molecular signature that can be used to predict outcomes of regorafenib treatment in patients with recurrent glioblastoma.
Neuroophthalmological Late Effects Common in Pediatric/Adolescent Medulloblastoma
Children and adolescents with medulloblastoma frequently suffer from neuroophthalmological sequelae, a single-center study suggests.
Risk of COVID-19 and Poor Outcomes Not Increased Among Glioma Patients
Patients with glioma do not have an increased risk of SARS-CoV-2 infection or worse outcomes from COVID-19, a single-center study suggests.
Deaths on the Rise in Patients With Malignant Brain Tumors
Deaths among patients with primary malignant brain tumors are on the rise in the United States, data suggest.
High Risk of Endo-Metabolic and Neuro-Behavioral Comorbidities in Optic Pathway Glioma Survivors
The etiology of comorbidities depends on hypothalamic tumor location and treatments received.
Pediatric Cancer Patients Treated With RT May Have Increased Risk of Meningioma for 30 Years
Patients who undergo radiotherapy for the treatment of childhood cancer have an increased risk of developing meningioma later in life, and that risk may persist for 30 years.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...